GSK Stockmann contributed to the publication of the Chinese Outbound Investment Guide 2018

IFLR is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement


GSK Stockmann contributed to the publication of the Chinese Outbound Investment Guide 2018

Sponsored by

23GSKLuxemburg.png

The Chinese Outbound Investment Guide 2018 has been published by International Financial Law Review (IFLR) and looks at the changes that have been occurring in Chinese outbound investment patterns and how target markets are adapting.

The guide covers numerous jurisdictions such as Bangladesh, France, Lebanon, Luxembourg, Offshore jurisdictions, South-Africa, Switzerland, Taiwan and Turkey, and examines the effects of the sudden acceleration in Chinese outbound investment over 2015 and 2016 across all sectors that underwent a fundamental change in 2017 to become more targeted. For each chapter, the publication provides a general outlook and looks into investment approval, investment techniques, dispute resolution, forex controls and local operations as well as tax.

GSK Stockmann contributed to the guide: Dr. Marcus Peter (lawyer and Partner at our GSK Stockmann office in Luxembourg) and Yi Wang (Associate at our GSK Stockmann office in Luxembourg) composed the chapter “Luxembourg“.

The guide is now free to access on the adjoining Website.

Link : Chinese Outbound Investment Guide 2018 online

Gift this article